avanza salud renal familiar

20
Avanza Salud Renal Familiar Milagros Heras, Emilio Rodrigo, ALM de Francisco, Alberto Ortiz SEN

Upload: locke

Post on 07-Jan-2016

21 views

Category:

Documents


3 download

DESCRIPTION

Avanza Salud Renal Familiar. Milagros Heras, Emilio Rodrigo, ALM de Francisco, Alberto Ortiz SEN. Background-1. 63-year-old female starts dialysis Family History Both parents death, no high BP nor renal disease A healthy brother 9 children, 2 gout. Medical history - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Avanza Salud Renal Familiar

AvanzaSalud Renal Familiar

Milagros Heras, Emilio Rodrigo, ALM de Francisco, Alberto Ortiz

SEN

Page 2: Avanza Salud Renal Familiar

Background-1• 63-year-old female starts dialysis

• Family History

• Both parents death, no high BP nor renal disease

• A healthy brother

• 9 children, 2 gout

• 3 years after her death, 67-year-old brother starts dialysis

•Hypertension, atherosclerosis

•Obesity

•ESRD attributed to hypertensive nephroangiosclerosis

•Medical history•CKD sCr 2,5 mg/dL, detected 1 year earlier•Hypertension•Obesity•Gout: negative screening for lead intoxication•Proteinuria 1.5 g/d•Small kidneys

•Dies 6 years later

Page 3: Avanza Salud Renal Familiar

Comments

• Family history may become outdated

• Advanced age does not exclude familial incidence of ESRD

• Familial screening may have identified relatives with CKD leading to medical care

• Hypertension, obesity

Page 4: Avanza Salud Renal Familiar

Genetics

vs

Environment

Background-2

Page 5: Avanza Salud Renal Familiar

• Familial incidence of ESRD (after exclusion of ADPKD and known hereditary disorders)

• Even for ESRD caused by different etiologic factors

• Most studies from the US: may not apply to Europe– High proportion of African Americans

– High prevalence of morbid obesity

Background-3

Page 6: Avanza Salud Renal Familiar

Background-4• ESRD patients have a 2.7-9 fold greater risk of having a relative with ESRD than the general

population (Lei JASN 1998)

• 23% of 25.000 US ESRD patients had a relative with ESRD (excluding known hereditary disease and urologic causes of ESRD) (Friedman Am J Nephrol 2005)

• 28% of 594 Canadian patients (vs 15% in control spouses) (O´Dea AJKD 1998)

• 11% of Polish patients (Gumprecht et al. J Nephrol 2003)

• Familial ESRD associated to:– Afro-american (in general, non-white)– Female sex– Etiology of ESRD: diabetes, hypertension, glomerulonephritis– Obesity– Earlier age at onset of ESRD

Page 7: Avanza Salud Renal Familiar

33% of physicians do not know that there is an increased incidence of ESRD in relatives of ESRD patients

Page 8: Avanza Salud Renal Familiar

AIMS

• To study the prevalence of familial ESRD and CKD among ESRD patients in Spain

• To identify and offer advice to families with CKD or ESRD

Page 9: Avanza Salud Renal Familiar

Secondary aims

• To identify risk factors for familial ESRD in Spain

• To study the prevalence of occult CKD (sCr, albuminuria) among relatives of ESRD patients in Spain: early treatment

• To identify new familial nephropathies (not diagnosed or not described)

• Identify genetic risk factors for progression to ESRD

Page 10: Avanza Salud Renal Familiar

Work plan

Pilot studyNationwide

study

A) Transversal epidemiological study

•Interview of ESRD patients

•Study of occult CKD in first degree relatives

B) Identification, study and follow-up of families with 2 or more members with CKD or ESRD

•Contact family members

•Instruct them to contact their physicians: physical exam plus basic analytical studies

•Offer specialized follow-up

Page 11: Avanza Salud Renal Familiar

Pilot study (H Valdecilla, Santander)

• Direct interview in dialysis patients, by phone in trasplant patients

• Two interviews within 2 weeks

Page 12: Avanza Salud Renal Familiar

Pilot study

Page 13: Avanza Salud Renal Familiar

Pilot study

• ESRD patients at H Valdecilla (Aug 25, 2006): 459

• Interviewed to date: (excluding ADPKD and other known hereditary diseases): 220 (133 HD y 87 Tx)

– Sex Male 152 (69%) Female 68 (31%)

– Age at initiation of RRT: 54 17 (11-85 years)

– Race: White 99%, Black: 2 (0.9%)

Page 14: Avanza Salud Renal Familiar

Pilot study. Cause of ESRD

• GN 61 (27.7%)

• DM 32 (14.5%)

• Vascular 57 (25.9%)

• Unknown 9 (4.1%)

• Interstitial 36 (16.4%)

• Others 25 (12%)

Page 15: Avanza Salud Renal Familiar

Pilot study. Prevalence of DM, hypertension, obesity

• DM 53 (24.2%)

• HTA 177 (80.8%)

• Obesity 34 (15.5%)

• Overweight 107 (49.5%)

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

100%

Pilot s tudy US s tudy

Norm al or decreased

Overweight

Obes ity

Morbid obes ity

Page 16: Avanza Salud Renal Familiar

Pilot study: ESRD or CKD in relatives

• ESRD– first degree relatives: 8 (3.6%)– second degree relatives : 6 (2.7%)– Any ESRD relative: 14 (6.4%)

• CKD– first degree relatives : 25 (11.4%)– second degree relatives : 20 (9.1%)– Any CKD relative : 43 (19.5%)

Page 17: Avanza Salud Renal Familiar

Pilot study: Presence of DM or hypertension in relatives

• DM– first degree relatives: 84 (38.2%)– second degree relatives: 57 (25.9%)– Any: 107 (48.6%)

• Hypertension– first degree relatives: 112 (50.9%)– second degree relatives : 52 (23.6%)– Any: 128 (58.2%)

Page 18: Avanza Salud Renal Familiar

Pilot study: associations with familial CKD

CKD 1+2 degree relative (43) No CKD (177) pSex (female) 44% 28% 0.036Cause of CKDGNDMVascularUnknownInterstitialOther

25.5%18.6%32.5%2.3%16.2%4.6%

28.2%13.5%24.2%4.5%16.3%12.9%

0.530

High BP 88.3% 78.9% 0.161DM 25.5% 23.8% 0.814Obesity 16.6% 15.5% 0.854Overweight 40.4% 51.7% 0.191

Page 19: Avanza Salud Renal Familiar

Pilot study: associations with familial CKD

CKD 1+2 degree relative (43) No CKD (177) pSex (female) 44% 28% 0.036Cause of CKDGNDMVascularUnknownInterstitialOther

25.5%18.6%32.5%2.3%16.2%4.6%

28.2%13.5%24.2%4.5%16.3%12.9%

0.530

High BP 88.3% 78.9% 0.161DM 25.5% 23.8% 0.814Obesity 16.6% 15.5% 0.854Overweight 40.4% 51.7% 0.191

Page 20: Avanza Salud Renal Familiar

Conclusions

• Pilot study– A significant proportion of Spanish ESRD patients have relatives with CKD or ESRD.

– While ESRD and diabetes were clearly identified, there was less knowledge about family history of hypertension and CKD

– The second interview generally did not improve the quality of the information

– Does the increase prevalence of familial ESRD in females reflect better knowledge of family matters?

• General– A more extensive study is warranted

– European figures may be lower than in the US

– Study of occult CKD in relatives of ESRD patients may uncover patients who will benefit from early treatment